Lakhdar, Rachid <br/><br/>
Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.  [electronic resource] 

 -  Journal of cardiac failure  Apr 2008 
 - 181-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1532-8414 
<br/><br/><label>Standard No.: </label>10.1016/j.cardfail.2007.11.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Echocardiography, Doppler<br/>Electrocardiography<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Severity of Illness Index<br/>Survival Analysis<br/>Treatment Outcome<br/>Ventricular Dysfunction, Left--diagnosis